TVRD · Tvardi Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| CHALMERS DEREK T President & CEO | ▼ Sell | Open Market | 991,405 Shares held | 9/7/2021 | View profile |
| VOGELBAUM MARTIN Director | ▲ Buy | Grant | 411,007 Shares held | 6/4/2024 | View profile |
| Shaheen Wirk | ▼ Sell | Other | 263,164 Shares held | 4/15/2025 | View profile |
| Shiff Susan Ph.D. Director | ▲ Buy | Grant | 202,085 Shares held | 6/4/2024 | View profile |
| HALL WALLACE L JR | ▼ Sell | Other | 202,044 Shares held | 4/15/2025 | View profile |
| Jeffrey L. Ives Director | ▲ Buy | Grant | 198,485 Shares held | 6/4/2024 | View profile |
| von Moltke Lisa Director | ▲ Buy | Grant | 183,009 Shares held | 6/4/2024 | View profile |
| Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | ▲ Buy | Grant | 167,247 Shares held | 2/1/2024 | View profile |
| Boudreau Helen M | ▲ Buy | Grant | 150,647 Shares held | 6/4/2024 | View profile |
| BAINS HARRISON M JR Director | ▲ Buy | Grant | 57,438 Shares held | 6/1/2023 | View profile |
| Joana Goncalves Chief Medical Officer | ▼ Sell | Open Market | 53,365 Shares held | 4/5/2024 | View profile |
| Reilly Thomas Charles SVP and CFO | ▼ Sell | Open Market | 37,811 Shares held | 3/3/2022 | View profile |
| Makara Richard VP, Head of Accting;Controller | ▲ Buy | Grant | 13,583 Shares held | 6/15/2022 | View profile |
| Maynard Ryan D Director | ▲ Buy | Grant | 13,500 Shares held | 2/1/2024 | View profile |
| Posner Christopher Director | ▼ Sell | Open Market | 13,109 Shares held | 2/28/2025 | View profile |
| Terrillion Scott Sec'y; Chief Compliance & G.C. | ▼ Sell | Open Market | 7,190 Shares held | 2/28/2025 | View profile |
| Tweardy Samuel David | ▼ Sell | Other | 0 Shares held | 7/7/2025 | View profile |
Transaction History
| Tweardy Samuel David | ▼ Sell | Other | 315,658 | $0 | 7/7/2025 |
| Tweardy Samuel David | ▼ Sell | Other | 315,658 | $0 | 7/7/2025 |
| HALL WALLACE L JR | ▼ Sell | Other | 44,712 | — | 4/15/2025 |
| HALL WALLACE L JR | ▼ Sell | Other | 202,044 | — | 4/15/2025 |
| Shaheen Wirk | ▲ Buy | Grant | 4,191 | — | 4/15/2025 |
| Shaheen Wirk | ▼ Sell | Other | 176,030 | — | 4/15/2025 |
| Shaheen Wirk | ▼ Sell | Other | 263,164 | — | 4/15/2025 |
| Posner Christopher | ▼ Sell | Open Market | 583 | $3K | 2/28/2025 |
| Terrillion Scott | ▼ Sell | Open Market | 163 | $776 | 2/28/2025 |
| Posner Christopher | ▼ Sell | Open Market | 372 | $2K | 2/4/2025 |
| Posner Christopher | ▼ Sell | Open Market | 3,668 | $1K | 11/4/2024 |
| Posner Christopher | ▼ Sell | Open Market | 4,149 | $1K | 8/1/2024 |
| VOGELBAUM MARTIN | ▲ Buy | Grant | 301,295 | $0 | 6/4/2024 |
| Shiff Susan Ph.D. | ▲ Buy | Grant | 150,647 | $0 | 6/4/2024 |
| Jeffrey L. Ives | ▲ Buy | Grant | 150,647 | $0 | 6/4/2024 |
| von Moltke Lisa | ▲ Buy | Grant | 150,647 | $0 | 6/4/2024 |
| Boudreau Helen M | ▲ Buy | Grant | 150,647 | $0 | 6/4/2024 |
| Posner Christopher | ▼ Sell | Open Market | 3,936 | $3K | 5/2/2024 |
| Joana Goncalves | ▼ Sell | Open Market | 2,753 | $2K | 4/5/2024 |
| Terrillion Scott | ▼ Sell | Open Market | 2,753 | $2K | 4/5/2024 |
| Posner Christopher | ▼ Sell | Open Market | 5,834 | $5K | 2/29/2024 |
| Joana Goncalves | ▼ Sell | Open Market | 3,293 | $3K | 2/29/2024 |
| Terrillion Scott | ▼ Sell | Open Market | 3,293 | $3K | 2/29/2024 |
| Posner Christopher | ▼ Sell | Open Market | 35,575 | $19K | 2/8/2024 |
| Terrillion Scott | ▲ Buy | Grant | 13,500 | $0 | 2/1/2024 |
| Maynard Ryan D | ▲ Buy | Grant | 13,500 | $0 | 2/1/2024 |
| Joana Goncalves | ▲ Buy | Grant | 13,500 | $0 | 2/1/2024 |
| Menzaghi Frederique Ph.D. | ▲ Buy | Grant | 13,500 | $0 | 2/1/2024 |
| Posner Christopher | ▲ Buy | Grant | 62,500 | $0 | 2/1/2024 |
| Posner Christopher | ▼ Sell | Open Market | 4,981 | $3K | 2/1/2024 |
| Posner Christopher | ▼ Sell | Open Market | 3,796 | $5K | 11/2/2023 |
| Posner Christopher | ▼ Sell | Open Market | 4,307 | $13K | 8/3/2023 |
| Terrillion Scott | ▼ Sell | Open Market | 2,483 | $9K | 6/23/2023 |
| Menzaghi Frederique Ph.D. | ▼ Sell | Open Market | 2,993 | $11K | 6/23/2023 |
| Joana Goncalves | ▼ Sell | Open Market | 2,723 | $10K | 6/23/2023 |
| von Moltke Lisa | ▲ Buy | Grant | 32,362 | $0 | 6/1/2023 |
| Shiff Susan Ph.D. | ▲ Buy | Grant | 32,362 | $0 | 6/1/2023 |
| Jeffrey L. Ives | ▲ Buy | Grant | 32,362 | $0 | 6/1/2023 |
| BAINS HARRISON M JR | ▲ Buy | Grant | 32,362 | $0 | 6/1/2023 |
| VOGELBAUM MARTIN | ▲ Buy | Grant | 64,724 | $0 | 6/1/2023 |
| Posner Christopher | ▼ Sell | Open Market | 3,869 | $17K | 5/5/2023 |
| Terrillion Scott | ▼ Sell | Open Market | 2,481 | $12K | 4/4/2023 |
| Joana Goncalves | ▼ Sell | Open Market | 2,481 | $12K | 4/4/2023 |
| Menzaghi Frederique Ph.D. | ▼ Sell | Open Market | 2,733 | $13K | 4/4/2023 |
| Posner Christopher | ▼ Sell | Open Market | 5,987 | $58K | 3/3/2023 |
| Menzaghi Frederique Ph.D. | ▼ Sell | Open Market | 6,802 | $66K | 3/3/2023 |
| Terrillion Scott | ▼ Sell | Open Market | 6,256 | $61K | 3/3/2023 |
| Joana Goncalves | ▼ Sell | Open Market | 6,221 | $60K | 3/3/2023 |
| Joana Goncalves | ▼ Sell | Open Market | 2,265 | $23K | 2/16/2023 |
| Terrillion Scott | ▼ Sell | Open Market | 7,770 | $4K | 2/8/2023 |
| Maynard Ryan D | ▼ Sell | Open Market | 5,488 | $3K | 2/8/2023 |
| Joana Goncalves | ▼ Sell | Open Market | 7,770 | $4K | 2/8/2023 |
| Posner Christopher | ▼ Sell | Open Market | 4,191 | $49K | 2/2/2023 |
| Joana Goncalves | ▼ Sell | Open Market | 2,265 | $24K | 1/17/2023 |
| Joana Goncalves | ▼ Sell | Open Market | 2,265 | $23K | 12/29/2022 |
| Menzaghi Frederique Ph.D. | ▼ Sell | Open Market | 3,506 | $40K | 12/21/2022 |
| Joana Goncalves | ▼ Sell | Open Market | 2,992 | $34K | 12/21/2022 |
| Terrillion Scott | ▼ Sell | Open Market | 2,561 | $29K | 12/21/2022 |
| Posner Christopher | ▼ Sell | Open Market | 14,470 | $161K | 11/16/2022 |
| VOGELBAUM MARTIN | ▼ Sell | Open Market | 10,800 | $111K | 9/14/2022 |
| Jeffrey L. Ives | ▼ Sell | Open Market | 3,600 | $33K | 7/15/2022 |
| BAINS HARRISON M JR | ▼ Sell | Open Market | 7,200 | $65K | 7/15/2022 |
| Makara Richard | ▲ Buy | Grant | 7,500 | $0 | 6/15/2022 |
| Shiff Susan Ph.D. | ▲ Buy | Grant | 11,876 | $0 | 6/2/2022 |
| Jeffrey L. Ives | ▲ Buy | Grant | 11,876 | $0 | 6/2/2022 |
| BAINS HARRISON M JR | ▲ Buy | Grant | 11,876 | $0 | 6/2/2022 |
| VOGELBAUM MARTIN | ▲ Buy | Grant | 23,752 | $0 | 6/2/2022 |
| VOGELBAUM MARTIN | ▲ Buy | Grant | 11,876 | $0 | 6/2/2022 |
| Posner Christopher | ▼ Sell | Open Market | 2,006 | $25K | 4/4/2022 |
| Terrillion Scott | ▼ Sell | Open Market | 1,642 | $20K | 4/1/2022 |
| Joana Goncalves | ▼ Sell | Open Market | 1,642 | $20K | 4/1/2022 |
| Menzaghi Frederique Ph.D. | ▼ Sell | Open Market | 1,784 | $21K | 4/1/2022 |
| Reilly Thomas Charles | ▼ Sell | Open Market | 2,044 | $23K | 3/3/2022 |
| Terrillion Scott | ▼ Sell | Open Market | 1,787 | $20K | 3/3/2022 |
| Terrillion Scott | ▲ Buy | Grant | 5,333 | $0 | 2/28/2022 |
| Reilly Thomas Charles | ▲ Buy | Grant | 5,333 | $55K | 2/28/2022 |
| Terrillion Scott | ▲ Buy | Grant | 20,000 | $0 | 2/25/2022 |
| Terrillion Scott | ▼ Sell | Open Market | 1,972 | $20K | 2/25/2022 |
| Reilly Thomas Charles | ▲ Buy | Grant | 20,000 | $0 | 2/25/2022 |
| Posner Christopher | ▲ Buy | Grant | 39,000 | $0 | 2/25/2022 |
| Menzaghi Frederique Ph.D. | ▲ Buy | Grant | 20,000 | $0 | 2/25/2022 |
| Menzaghi Frederique Ph.D. | ▼ Sell | Open Market | 2,114 | $22K | 2/25/2022 |
| Joana Goncalves | ▲ Buy | Grant | 20,000 | $0 | 2/25/2022 |
| Joana Goncalves | ▼ Sell | Open Market | 1,972 | $20K | 2/25/2022 |
| Menzaghi Frederique Ph.D. | ▲ Buy | Grant | 12,607 | $0 | 12/17/2021 |
| Joana Goncalves | ▲ Buy | Grant | 12,607 | $0 | 12/17/2021 |
| Terrillion Scott | ▲ Buy | Grant | 11,495 | $0 | 12/17/2021 |
| Reilly Thomas Charles | ▲ Buy | Grant | 11,170 | $0 | 12/17/2021 |
| Jeffrey L. Ives | ▼ Sell | Open Market | 8,180 | $131K | 11/12/2021 |
| Joana Goncalves | ▼ Sell | Open Market | 1,000 | $17K | 11/1/2021 |
| Posner Christopher | ▲ Buy | Grant | 5,941 | $0 | 10/29/2021 |
| Posner Christopher | ▲ Buy | Grant | 142,000 | $0 | 10/29/2021 |
| Joana Goncalves | ▼ Sell | Open Market | 1,000 | $15K | 10/27/2021 |
| CHALMERS DEREK T | ▼ Sell | Open Market | 20,000 | $309K | 9/7/2021 |
| Terrillion Scott | ▼ Sell | Open Market | 1,759 | $25K | 8/30/2021 |
| Reilly Thomas Charles | ▼ Sell | Open Market | 1,982 | $28K | 8/30/2021 |
| Menzaghi Frederique Ph.D. | ▼ Sell | Open Market | 3,847 | $55K | 8/30/2021 |
| Joana Goncalves | ▼ Sell | Open Market | 2,110 | $30K | 8/30/2021 |
| CHALMERS DEREK T | ▼ Sell | Open Market | 8,440 | $120K | 8/30/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Tvardi releases preclinical data on STAT3 inhibitor for UC
Tvardi Therapeutics reported new preclinical results that show its STAT3 inhibitor may be effective in treating ulcerative colitis. The data were published in the International Journal of Molecular Sciences. The announcement appeared in recent market round‑ups of health‑care stocks moving in pre‑market and after‑hours sessions.
Tvardi releases preclinical data on STAT3 inhibitor for UC. Tvardi Therapeutics reported new preclinical results that show its STAT3 inhibitor may be effective in treating ulcerative colitis. The data were published in the International Journal of Molecular Sciences. The announcement appeared in recent market round‑ups of health‑care stocks moving in pre‑market and after‑hours sessions.